Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 517 entries
View as:

A Study of Fluzoparib±Apatinib Versus Chemotherapy Treatment of Physician's Choice in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation

Phase: N/A Priority: Normal
NCT ID: NCT04296370 Org: User:
Start: 07/13/20 End: 06/30/25 Due: 06/30/26

A Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT05254366 Org: User:
Start: 02/28/22 End: 12/31/22 Due: 12/31/23

A Itraconazole Effect Study of SHR2554 on Healthy Chinese Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04627129 Org: User:
Start: 06/01/20 End: 10/01/20 Due: 10/01/21

SHR - 1209 Treatment Efficacy and Safety of the Patients With Hypercholesterolemia Ⅲ Period Clinical Research

Phase: N/A Priority: Normal
NCT ID: NCT04844125 Org: User:
Start: 04/14/21 End: 08/12/22 Due: 08/12/23

Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT03971929 Org: User:
Start: 07/31/19 End: 09/03/20 Due: 09/03/21

A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05333835 Org: User:
Start: 07/08/22 End: 03/30/24 Due: 03/30/25

The PK/PD Study of Single Dose of SHR3824 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02356224 Org: User:
Start: 06/30/13 End: 12/31/13 Due: 12/31/14

A Phase 4 Study of Imrecoxib in Treatment of Knee Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT01985165 Org: User:
Start: 05/31/13 End: - Due: -

A Study of Remimazolam Tosilate for Sedation in the Upper Gastrointestinal Endoscopy

Phase: N/A Priority: Normal
NCT ID: NCT06169995 Org: User:
Start: 12/11/23 End: 12/16/23 Due: 12/16/24

Effect of Itraconazole on the Pharmacokinetics of Apatinib

Phase: N/A Priority: Normal
NCT ID: NCT02836171 Org: User:
Start: 07/31/16 End: 02/28/17 Due: 02/28/18

A Study of Apatinib in Patients With Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01192971 Org: User:
Start: 06/30/10 End: 07/31/13 Due: 07/31/14

To Evaluate the Safety and Tolerability of Combined Administration of SHR2285 Tablets With Aspirin, Clopidogrel or Ticagrelor in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04945616 Org: User:
Start: 07/13/21 End: 06/15/22 Due: 06/15/23

Drug-drug Interaction Between Simvastatin and SHR3824

Phase: N/A Priority: Normal
NCT ID: NCT03329118 Org: User:
Start: 11/24/17 End: 12/08/17 Due: 12/08/18

A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive Recurrent or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06057610 Org: User:
Start: 10/16/23 End: 10/31/32 Due: 10/31/33

A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients

Phase: N/A Priority: Normal
NCT ID: NCT07036419 Org: User:
Start: 07/31/25 End: 03/31/26 Due: 03/31/27

Study of Remimazolam Tosilate in Patients Undergoing Colonoscopy

Phase: N/A Priority: Normal
NCT ID: NCT03779061 Org: User:
Start: 06/28/18 End: 09/28/18 Due: 09/28/19

Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04447118 Org: User:
Start: 09/11/20 End: 10/31/23 Due: 10/31/24

A Drug-drug Interaction Trial of Loperamide Pharmacokinetics Effect on Pyrotinib Maleate

Phase: N/A Priority: Normal
NCT ID: NCT04315116 Org: User:
Start: 04/13/20 End: 09/01/20 Due: 09/01/21

Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT04390984 Org: User:
Start: 05/26/20 End: 03/31/21 Due: 03/31/22

A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04624217 Org: User:
Start: 11/24/20 End: 02/08/23 Due: 02/08/24

Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06093945 Org: User:
Start: 11/06/23 End: 11/29/23 Due: 11/29/24

The Single, Multiple Dose and Food Effect Study of SHR2285 Tablets on Pharmacokinetics and Pharmacodynamics in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04472819 Org: User:
Start: 08/28/20 End: 05/31/21 Due: 05/31/22

Single Dose Study To Study The Absorption, Metabolism And Excretion Of Famitinib

Phase: N/A Priority: Normal
NCT ID: NCT05473468 Org: User:
Start: 08/26/22 End: 11/30/22 Due: 11/30/23

A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01965496 Org: User:
Start: 03/31/12 End: 04/30/13 Due: 04/30/14

A Study of SHR6390 in Advanced Solid Tumor Patients

Phase: N/A Priority: Normal
NCT ID: NCT02684266 Org: User:
Start: 03/03/16 End: 06/28/19 Due: 06/28/20